T cell receptor (TCR) on CD4+ T helper cells recognizing poliovirus-derived peptides (Polio-specific CD4+ TCR)

The T cell receptor (TCR) on CD4+ T helper cells specific for poliovirus-derived peptides is a fundamental mediator of the adaptive immune response against the poliovirus. These receptors recognize specific viral epitopes, primarily derived from the capsid proteins VP1, VP2, and VP3, when they are presented by Major Histocompatibility Complex (MHC) class II molecules on the surface of professional antigen-presenting cells [1][2]. This recognition event, facilitated by the CD4 co-receptor, triggers a complex intracellular signaling cascade through the CD3 complex, leading to the activation and differentiation of the T helper cell [3]. Once activated, these cells play a pivotal role in the immune system by secreting pro-inflammatory cytokines and providing essential signals to B cells for the production of high-affinity neutralizing antibodies, which prevent the virus from infecting host cells [4][6]. In clinical practice, this TCR population is the primary target of both Inactivated Poliovirus Vaccines (IPV) and Oral Poliovirus Vaccines (OPV), which aim to establish long-lasting immunological memory [5]. Monitoring the frequency and specificity of these TCRs serves as a key indicator of vaccine-induced immunity and helps in the evaluation of global polio eradication efforts [5].

Other names

Poliovirus-specific T cell receptorMHC class II-restricted poliovirus T cell receptorCD4+ T cell receptor for poliovirus capsid proteinsPolio-specific CD4+ TCR

Vaccines provide viral antigens that are processed and presented as peptides on MHC class II molecules; the TCR recognizes these complexes, initiating a signaling cascade that results in T cell activation, cytokine release, and B cell assistance for antibody production [1][3][6].